Canada markets close in 2 hours 36 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5598+0.0097 (+1.76%)
As of 01:20PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 17.32M
Enterprise Value -5.39M
Trailing P/E 1.45
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.37
Price/Book (mrq)0.59
Enterprise Value/Revenue -1.67
Enterprise Value/EBITDA -0.44

Trading Information

Stock Price History

Beta (5Y Monthly) 1.70
52-Week Change 374.30%
S&P500 52-Week Change 3-13.20%
52 Week High 30.6200
52 Week Low 30.0920
50-Day Moving Average 30.5481
200-Day Moving Average 30.3699

Share Statistics

Avg Vol (3 month) 3897.6k
Avg Vol (10 day) 398.78k
Shares Outstanding 531.49M
Implied Shares Outstanding 6N/A
Float 825.37M
% Held by Insiders 111.36%
% Held by Institutions 124.99%
Shares Short (Nov 14, 2022) 4509.33k
Short Ratio (Nov 14, 2022) 43.25
Short % of Float (Nov 14, 2022) 41.63%
Short % of Shares Outstanding (Nov 14, 2022) 41.62%
Shares Short (prior month Oct 13, 2022) 4531.45k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 31.43
Trailing Annual Dividend Yield 3259.95%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sept 19, 2022
Ex-Dividend Date 4Sept 20, 2022
Last Split Factor 23803:1000
Last Split Date 3Sept 20, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 367.44%
Operating Margin (ttm)-1,259.34%

Management Effectiveness

Return on Assets (ttm)-46.47%
Return on Equity (ttm)26.37%

Income Statement

Revenue (ttm)3.23M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-64.91M
EBITDA -40.39M
Net Income Avi to Common (ttm)11.88M
Diluted EPS (ttm)0.3800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.09M
Total Cash Per Share (mrq)0.73
Total Debt (mrq)381k
Total Debt/Equity (mrq)1.30
Current Ratio (mrq)18.40
Book Value Per Share (mrq)0.93

Cash Flow Statement

Operating Cash Flow (ttm)-49.3M
Levered Free Cash Flow (ttm)-35.22M